Scientists test antibody duo to shrink HIV hideouts
NCT ID NCT05612178
Summary
This study is testing if two experimental antibody drugs are safe and can reduce the amount of hidden, dormant HIV in the body. The trial involves 105 adults with HIV who are on stable antiretroviral therapy. Participants receive three infusions of either the antibodies or a placebo over 40 weeks while continuing their regular HIV medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
-
The Rockefeller University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.